TrueBlue (TBI) Tops Q4 EPS by 7c
Tweet
Share
E-mailGet Alerts TBI Hot Sheet
Price: $8.75 --0%
Revenue Growth %: +5.4%
Financial Fact:
Interest expense: -1.72M
Today's EPS Names:
OCCI, VIVO, PMCB, More
Revenue Growth %: +5.4%
Financial Fact:
Interest expense: -1.72M
Today's EPS Names:
OCCI, VIVO, PMCB, More
Join SI Premium – FREE
TrueBlue (NYSE: TBI) reported Q4 EPS of $0.52, $0.07 better than the analyst estimate of $0.45. Revenue for the quarter came in at $691 million versus the consensus estimate of $699.2 million.
For earnings history and earnings-related data on TrueBlue (TBI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Evercore cuts HPE rating amid 'tougher setup'
- Akebia doses first patient in Phase 2 kidney disease trial
- Press Release: Sanofi and Cheplapharm to create new strategic partnership in mature medicines
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
